Description
This issue of Surgical Oncology Clinics of North America, guest edited by Dr. Kelly Hunt, is devoted to Changing Paradigms in Breast Cancer Diagnosis and Treatment. Dr. Hunt has assembled expert authors to review the following topics: Tomosynthesis in breast cancer imaging: how does it fit into preoperative evaluation and surveillance?; Lobular breast cancer: different disease, different algorithms?; Hypofractionated radiation therapy in breast conserving therapy; Oncoplastic breast reconstruction: should all patients be considered?; Neoadjuvant endocrine therapy: who benefits most?; Breast cancer disparities: how can we leverage genomics to improve outcomes?; Anatomy and breast cancer staging: is it still relevant?; When does atypical ductal hyperplasia require surgical intervention?; Surgical intervention for lymphedema; Are there alternative strategies in the local management of DCIS?; Genetic testing and genetic counseling: what is standard of care?; Molecular subtypes and local-regional control of breast cancer; Intraoperative margin assessment in breast cancer management; Triple negative breast cancer: who should receive neoadjuvant chemotherapy?; and more!
Table of Contents
Surgical Oncology ClinicsChanging Paradigms in Breast Cancer Diagnosis and TreatmentForeword: Innovation in the Diagnosis and Management of Breast CancerPreface: Integrating New Knowledge and Surgical Innovation into the Diagnosis and Management of Breast CancerConsiderations in Testing for Inherited Breast Cancer Predisposition in the Era of Personalized MedicineWhen Does Atypical Ductal Hyperplasia Require Surgical ExcisionTomosynthesis in Breast Cancer Imaging: How Does It Fit into Preoperative Evaluation and Surveillance?Anatomy and Breast Cancer Staging: Is It Still Relevant?Are There Alternative Strategies for the Local Management of Ductal Carcinoma in Situ?Lobular Breast Cancer: Different Disease, Different Algorithms?Molecular Subtypes and Local-Regional Control of Breast CancerNeoadjuvant Endocrine Therapy: Who Benefits Most?Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy?Intraoperative Margin Assessment in Breast Cancer ManagementOncoplastic Breast Reconstruction: Should All Patients be Considered?Alternatives to Standard Fractionation Radiation Therapy After Lumpectomy: Hypofractionated Whole-Breast Irradiation and Accelerated Partial-Breast IrradiationSurgical Intervention for LymphedemaBreast Cancer Disparities: How Can We Leverage Genomics to Improve Outcomes?
